Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells

被引:74
作者
Husbeck, B
Nonn, L
Peehl, DM
Knox, SJ
机构
[1] Stanford Univ, Med Ctr, Dept Radiat Oncol, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Urol, Stanford, CA USA
关键词
selenium; selenite; prostate cancer; glutathione; MnSOD;
D O I
10.1002/pros.20337
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Selenium compounds have been shown to induce apoptosis in a variety of human prostate cancer cell lines. However, the effects of selenium have yet to be examined in normal and malignant cells derived from the same individual. Selenite metabolism consumes glutathione (GSH) and produces superoxide. The generation of reactive oxygen species is an important mechanism in selenite-induced apoptosis. METHODS. Three patient-matched pairs of primary prostatic epithelial cell cultures from normal and cancer were evaluated for their response to selenite. Apoptosis was measured and the differential response of normal and cancer cells was correlated with the expression of bcl-2, bax, GSH, and manganese superoxide dismutase (MnSOD). RESULTS. The cancer-derived cells were significantly more sensitive to selenite-induced apoptosis than the corresponding normal cells. Tumor-selective killing was not observed in cells treated with selenomethionine. The ratio of bcl-2:bax was decreased in the cancer-derived cells treated with selenite. Total GSH concentrations were similar in paired normal and cancer cells. Therefore, differences in GSH content do not appear to play a role in tumor-selective killing by selenite. Superoxide is a by-product of selenite metabolism and normal cells showed increased MnSOD expression and SOD activity compared to the cancer-derived cells. Prostate cancer cells treated with the MnSOD mimetic, MnTMPyP, were protected against the cytotoxic effects of selenite. CONCLUSIONS. Higher MnSOD expression in normal cells may play an important role in eliminating superoxide radicals produced as a result of selenite metabolism and contribute to the tumor-selective killing by selenite in prostate cancer.
引用
收藏
页码:218 / 225
页数:8
相关论文
共 35 条
  • [1] The Bcl-2 protein family: Arbiters of cell survival
    Adams, JM
    Cory, S
    [J]. SCIENCE, 1998, 281 (5381) : 1322 - 1326
  • [2] [Anonymous], CULTURES
  • [3] Baker AM, 1997, PROSTATE, V32, P229, DOI 10.1002/(SICI)1097-0045(19970901)32:4<229::AID-PROS1>3.0.CO
  • [4] 2-E
  • [5] Sensitivity of melphalan-resistant tumors to selenite in vivo
    Caffrey, PB
    Frenkel, GD
    [J]. CANCER LETTERS, 1997, 121 (02) : 177 - 180
  • [6] INCREASED MANGANESE SUPEROXIDE-DISMUTASE EXPRESSION SUPPRESSES THE MALIGNANT PHENOTYPE OF HUMAN-MELANOMA CELLS
    CHURCH, SL
    GRANT, JW
    RIDNOUR, LA
    OBERLEY, LW
    SWANSON, PE
    MELTZER, PS
    TRENT, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (07) : 3113 - 3117
  • [7] Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin a randomized controlled trial - A randomized controlled trial
    Clark, LC
    Combs, GF
    Turnbull, BW
    Slate, EH
    Chalker, DK
    Chow, J
    Davis, LS
    Glover, RA
    Graham, GF
    Gross, EG
    Krongrad, A
    Lesher, JL
    Park, HK
    Sanders, BB
    Smith, CL
    Taylor, JR
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (24): : 1957 - 1963
  • [8] Chemopreventive agents: Selenium
    Combs, GF
    Gray, WP
    [J]. PHARMACOLOGY & THERAPEUTICS, 1998, 79 (03) : 179 - 192
  • [9] Combs Jr G.F., 1997, ANTIOXIDANTS DIS PRE, V14, P97
  • [10] Inorganic selenium retards progression of experimental hormone refractory prostate cancer
    Corcoran, NM
    Najdovska, M
    Costello, AJ
    [J]. JOURNAL OF UROLOGY, 2004, 171 (02) : 907 - 910